Tender Details

Country: USA
Summary: Behavioral And Integrative Treatment Development Program (R34 Clinical Trial Optional)
UST Ref No: 113608833
Deadline: 07 May 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: PAR-24-300
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
The Purpose Of This Funding Opportunity Announcement (Foa) Is To Encourage Behavioral Intervention Development Research To Test Efficacy, Conduct Clinical Trials, Examine Mechanisms Of Behavior Change, Determine Dose-Response, Treatment Optimization, And/Or Ascertain Best Sequencing Of Behavioral, Combined, Sequential, Or Integrated Behavioral And Pharmacological (1) Drug Abuse Treatment Interventions, Including Interventions For Patients With Comorbidities; (2) Drug Abuse Treatment And Adherence Interventions; (3) Drug Abuse Treatment And Adherence Interventions That Utilize Technologies To Boost Effects And Increase Implementability And Sustainability; (4) Interventions To Prevent The Acquisition Or Transmission Of Hiv Infection Among Individuals In Drug Abuse Treatment; (5) Interventions To Promote Adherence To Drug Abuse Treatment, Hiv And Addiction Medications; And (6) Interventions To Treat Substance Misuse And Chronic Pain. Research Of Interest Includes But Is Not Limited To Stage I Research.
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Behavioral And Integrative Treatment Development Program (R34 Clinical Trial Optional) - USA Tender

The NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Behavioral And Integrative Treatment Development Program (R34 Clinical Trial Optional). This tender is published on USARFP under UST Ref No: 113608833 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-05-07.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.